glutamic acid and Prostatic Neoplasms

glutamic acid has been researched along with Prostatic Neoplasms in 30 studies

Research

Studies (30)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (6.67)	18.2507
2000's	8 (26.67)	29.6817
2010's	14 (46.67)	24.3611
2020's	6 (20.00)	2.80

Authors

Authors	Studies
Bansal, N; Gupta, A; Kumar, D; Kumar, M; Lal, H; Mandhani, A; Sankhwar, SN	1
Li, J; Lin, Y; Luo, Y; Qu, Z; Sun, Y; Yang, Z; Zhang, L; Zhang, X	1
Armiñán, A; Baues, M; De Lorenzi, F; Gallon, E; Lammers, T; Maso, K; May, JN; Movellan, J; Rodríguez-Otormín, F; Vicent, MJ; Vicente-Ruiz, S; Zagorodko, O	1
Dereziński, P; Garrett, TJ; Joshi, P; Lee, B; Mahmud, I; Marchica, J; Patel, V; Pavlovich, CP; Perera, RJ; Qi, F; Rivera, I; Schroth, GP; Sun, Y; Valerio, F; Wang, F	1
Amini, M; Atyabi, F; Dinarvand, R; Goodarzi, N; Saeedian Moghadam, E; Saniee, F; Shabani Ravari, N	1
Lu, L; Ma, D; Xi, Z; Yang, C; Yang, X	1
Hino, R; Kamiya, M; Umezawa, K; Urano, Y; Yogo, T	1
Emerling, BM; Palamiuc, L	1
Chun, S; Chung, HJ; Jeong, BH; Kim, HK; Kwon, YD; La, MT; Lee, SH; Lee, SJ; Oh, JM	1
Perry, RJ; Rabin-Court, A; Rodrigues, MR; Zhang, XM	1
Babich, JW; Eckelman, WC; Hillier, SM; Joyal, JL; Lu, G; Maresca, KP; Marquis, JC; Merkin, RD; Zimmerman, CN	1
Huang, B; Joice, M; Kotlyar, A; Otis, J; Thomas, TP	1
Gao, L; Pan, T; Qian, W; Shen, G; Tu, Z; Wen, H; Wu, G; Xie, S; Yang, J; Zhou, Y	1
Huang, T; Landman, J; Wang, PJ; Yang, AQ; Zhou, WL	1
Barlos, D; Barton, BE; Donnelly, RJ; Ginjupalli, K; Husain, A; Lewis, HD; Riaz, S; Shodeinde, A	1
Chen, X; Hoffman, TJ; Jackson, AB; Nanda, PK; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF	1
Cho, SY; Foss, CA; Kim, HJ; Mease, RC; Pomper, MG	1
Chen, Z; Ding, Q; Dong, P; Gao, X; He, D; Jiang, H; Jiao, Y; Lin, X; Liu, F; Lu, D; Mo, Z; Na, R; Ou-Yang, J; Qi, J; Qu, L; Ren, S; Shao, Q; Shi, R; Sun, J; Sun, Y; Tao, S; Turner, AR; Wang, G; Wang, M; Wang, X; Wang, Z; Wu, D; Wu, Q; Xu, C; Xu, J; Xu, Y; Yang, J; Ye, D; Yin, C; Yuan, J; Zhang, Z; Zheng, SL; Zheng, Y; Zhou, F; Zhu, Y	1
Attwood, K; Azabdaftari, G; Koochekpour, S; Lorusso, GD; Majumdar, S; Manhardt, C; Mohler, JL; Rezaei, K; Sartor, O; Scioneaux, R; Shourideh, M; Subramani, D; Thompson, H; Vessella, RL; Willard, SS	1
Abdel Rahman, DE; Hassan, GS	1
Berkman, CE; Hosaka, M; Kamga, I; Ng, R	1
Costa, S; Ferreira, P; Lopes, C; Medeiros, RM; Morais, A; Oliveira, J; Pinto, D; Vasconcelos, A	1
Ayala-Sanmartin, J; Liu, J; Rothermund, CA; Vishwanatha, JK	1
Denmeade, SR; Gady, AM; Gillies, SD; Lo, KM; Mhaka, A; Rosen, DM	1
Leach, F	1
Barinka, C; Hilgenfeld, R; Konvalinka, J; Li, W; Majer, P; Mesters, JR; Slusher, BS; Tsukamoto, T	1
Bryant, I; Fry, R; Gallo, RM; Riese, DJ; Williams, EE	1
Holle, E; Li, L; Song, W; Wagner, T; Warren, P; Wei, Y; Yu, X	1
Dalrymple, GV; Finkbeiner, AE; Fowler, AH; Holder, JC; Komoroski, RA; Mullins, MS; Pappas, AA; Sprigg, JR	1
Peehl, D; Sommer, G; Yacoe, ME	1

Reviews

1 review(s) available for glutamic acid and Prostatic Neoplasms

Article	Year
GCPII imaging and cancer. Current medicinal chemistry, 2012, Volume: 19, Issue:9 Topics: Animals; Antigens, Surface; Gene Expression Regulation, Neoplastic; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Molecular Imaging; Neoplasms; Prostate; Prostatic Neoplasms	2012

Trials

1 trial(s) available for glutamic acid and Prostatic Neoplasms

Article	Year
A novel germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men. The Prostate, 2013, Volume: 73, Issue:2 Topics: Aged; Aged, 80 and over; Amino Acid Substitution; Asian People; China; Genetic Predisposition to Disease; Germ-Line Mutation; Glutamic Acid; Glycine; Homeodomain Proteins; Humans; Male; Middle Aged; Prostatic Neoplasms	2013

Other Studies

28 other study(ies) available for glutamic acid and Prostatic Neoplasms

Article	Year
Metabolomics of prostate cancer: Knock-in versus knock-out prostate. Journal of pharmaceutical and biomedical analysis, 2021, Oct-25, Volume: 205 Topics: Biomarkers, Tumor; Glutamic Acid; Humans; Male; Metabolomics; Prostatic Neoplasms	2021
Effects of glutamate and aspartate on prostate cancer and breast cancer: a Mendelian randomization study. BMC genomics, 2022, Mar-16, Volume: 23, Issue:1 Topics: Adult; Aspartic Acid; Breast Neoplasms; Glutamic Acid; Humans; Male; Mendelian Randomization Analysis; Prostatic Neoplasms	2022
Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer. Biomaterials, 2023, Volume: 301 Topics: Animals; Cell Proliferation; Glutamic Acid; Humans; Male; Mice; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Polyethylene Glycols; Prostatic Neoplasms	2023
Integrated RNA and metabolite profiling of urine liquid biopsies for prostate cancer biomarker discovery. Scientific reports, 2020, 02-28, Volume: 10, Issue:1 Topics: Biomarkers, Tumor; Citric Acid Cycle; Glutamic Acid; Humans; Liquid Biopsy; Male; Prostate; Prostatic Neoplasms; RNA, Messenger	2020
Glutamate-urea-based PSMA-targeted PLGA nanoparticles for prostate cancer delivery of docetaxel. Pharmaceutical development and technology, 2021, Volume: 26, Issue:4 Topics: Antigens, Surface; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Docetaxel; Drug Carriers; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Inhibitory Concentration 50; Male; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglactin 910; Prostatic Neoplasms; Time Factors; Urea	2021
Synthesis of KUE-siRNA Conjugates for Prostate Cancer Cell-Targeted Gene Silencing. Chembiochem : a European journal of chemical biology, 2021, 10-01, Volume: 22, Issue:19 Topics: Antigens, Surface; Gene Silencing; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Prostatic Neoplasms; RNA, Small Interfering; Urea	2021
Development of an Activatable Fluorescent Probe for Prostate Cancer Imaging. Bioconjugate chemistry, 2017, 08-16, Volume: 28, Issue:8 Topics: Animals; Cell Line, Tumor; Fluorescent Dyes; Glutamic Acid; Humans; Male; Mice; Optical Imaging; Prostatic Neoplasms; Rhodamines; Serine Endopeptidases	2017
PSMA brings new flavors to PI3K signaling: A role for glutamate in prostate cancer. The Journal of experimental medicine, 2018, 01-02, Volume: 215, Issue:1 Topics: Antigens, Surface; Folic Acid; Glutamic Acid; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Receptors, Metabotropic Glutamate	2018
Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer. Bioconjugate chemistry, 2019, 01-16, Volume: 30, Issue:1 Topics: Animals; Antigens, Surface; Cell Hypoxia; Cell Line, Tumor; Female; Fluorescent Dyes; Glutamate Carboxypeptidase II; Glutamic Acid; Heterografts; Humans; Lysine; Male; Mice; Mice, Inbred BALB C; Prostatic Neoplasms; Tissue Distribution; Urea	2019
Obesity-associated, but not obesity-independent, tumors respond to insulin by increasing mitochondrial glucose oxidation. PloS one, 2019, Volume: 14, Issue:6 Topics: Alanine; Breast Neoplasms; Cell Line, Tumor; Citrate (si)-Synthase; Colonic Neoplasms; Female; Gene Expression Regulation; Glucose; Glutamic Acid; Humans; Insulin; Isotope Labeling; Ketone Oxidoreductases; Lymphoma, B-Cell; Male; Melanoma; Mitochondria; Obesity; Organ Specificity; Oxidation-Reduction; Phosphorylation; Prostatic Neoplasms; Receptor, Insulin; Signal Transduction; Skin Neoplasms; Small Cell Lung Carcinoma	2019
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Acetates; Animals; Antigens, Surface; Biological Transport; Cell Line, Tumor; Chelating Agents; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Mice; Molecular Imaging; Organotechnetium Compounds; Prostatic Neoplasms; Protease Inhibitors; Radiochemistry; Radionuclide Imaging; Technetium; Urea	2013
PSMA-targeted stably linked "dendrimer-glutamate urea-methotrexate" as a prostate cancer therapeutic. Biomacromolecules, 2014, Mar-10, Volume: 15, Issue:3 Topics: Antigens, Surface; Click Chemistry; Dendrimers; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Methotrexate; Nanoparticles; Prostatic Neoplasms; Urea	2014
Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Biochemical and biophysical research communications, 2015, Jan-02, Volume: 456, Issue:1 Topics: Adenosine Triphosphate; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA Interference	2015
Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells. Genetics and molecular research : GMR, 2016, Apr-04, Volume: 15, Issue:2 Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chitosan; Glutamic Acid; Humans; Inhibitor of Apoptosis Proteins; Male; Nanoparticles; Neoplasm Proteins; Polyethylene Glycols; Prostatic Neoplasms; RNA Interference; Survivin	2016
Creation of a novel peptide with enhanced nuclear localization in prostate and pancreatic cancer cell lines. BMC biotechnology, 2010, Oct-28, Volume: 10 Topics: Cell Line, Tumor; Cell-Penetrating Peptides; Glutamic Acid; Humans; Male; Nuclear Localization Signals; Organic Cation Transport Proteins; Pancreatic Neoplasms; Peptide Nucleic Acids; Prostatic Neoplasms	2010
64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer. Nuclear medicine and biology, 2012, Volume: 39, Issue:3 Topics: Aminocaproic Acid; Animals; Binding, Competitive; Bombesin; Cell Line, Tumor; Coordination Complexes; Copper Radioisotopes; Glutamic Acid; Heterocyclic Compounds; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Peptide Fragments; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution; Xenograft Model Antitumor Assays	2012
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Nov-01, Volume: 18, Issue:21 Topics: Adult; Apoptosis; Black or African American; Case-Control Studies; Cell Line, Tumor; Cell Movement; Cell Proliferation; Glutamic Acid; Humans; Male; Middle Aged; Neoplasm Grading; Prostate; Prostatic Neoplasms; Receptors, Metabotropic Glutamate; Riluzole; White People	2012
Synthesis and biological evaluation of some substituted-2-N-(5-chloro-2-methoxy-4-methylphenylsulphonyl) glutamic acid derivatives against prostate cancer cell line PC3. Chemical & pharmaceutical bulletin, 2013, Volume: 61, Issue:2 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glutamic Acid; Humans; Male; Prostatic Neoplasms; Quantitative Structure-Activity Relationship	2013
High-performance liquid chromatography method for detecting prostate-specific membrane antigen activity. Analytical biochemistry, 2002, Nov-01, Volume: 310, Issue:1 Topics: Antigens, Neoplasm; Antigens, Surface; Carboxypeptidases; Cell Membrane; Chromatography, High Pressure Liquid; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Hydrolysis; Male; Prostatic Neoplasms; Tritium; Tumor Cells, Cultured	2002
Outcome in prostate cancer: association with endothelial nitric oxide synthase Glu-Asp298 polymorphism at exon 7. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:11 Topics: Aged; Aspartic Acid; Bone Neoplasms; Disease Progression; Exons; Genotype; Glutamic Acid; Humans; Logistic Models; Male; Middle Aged; Neoplasm Metastasis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Prognosis; Prostatic Neoplasms; Treatment Outcome	2002
Nuclear annexin II negatively regulates growth of LNCaP cells and substitution of ser 11 and 25 to glu prevents nucleo-cytoplasmic shuttling of annexin II. BMC biochemistry, 2003, Sep-09, Volume: 4 Topics: Active Transport, Cell Nucleus; Amino Acid Substitution; Annexin A2; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Nucleus; Cytoplasm; Exportin 1 Protein; Glutamic Acid; Humans; Karyopherins; Male; Mutation; Phosphorylation; Prostatic Neoplasms; Protein Sorting Signals; Receptors, Cytoplasmic and Nuclear; Serine	2003
Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA). Cancer biology & therapy, 2004, Volume: 3, Issue:6 Topics: Animals; Antigens, Surface; Aspartic Acid; Blotting, Western; Extracellular Fluid; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Immunoglobulin gamma-Chains; Immunoglobulin kappa-Chains; Male; Methotrexate; Mice; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity; Tumor Cells, Cultured	2004
Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface? Cancer biology & therapy, 2004, Volume: 3, Issue:6 Topics: Antigens, Surface; Aspartic Acid; Drug Delivery Systems; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Male; Methotrexate; Peptide Fragments; Prodrugs; Prostatic Neoplasms; Recombinant Fusion Proteins; Substrate Specificity	2004
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. The EMBO journal, 2006, Mar-22, Volume: 25, Issue:6 Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Glycosylation; Humans; Hydrolysis; Male; Models, Molecular; Molecular Sequence Data; Neurons; Prostatic Neoplasms; Protein Conformation; Protein Folding; Recombinant Proteins	2006
Phosphorylation of ErbB4 on Tyr1056 is critical for inhibition of colony formation by prostate tumor cell lines. Biochemical and biophysical research communications, 2006, Oct-13, Volume: 349, Issue:1 Topics: Alternative Splicing; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Gene Expression Regulation, Neoplastic; Glutamic Acid; Humans; Male; Phosphorylation; Prostatic Neoplasms; Receptor, ErbB-4; Signal Transduction; Tyrosine	2006
In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two gamma-linked glutamate residues at the COOH terminus. Cancer research, 2001, Sep-15, Volume: 61, Issue:18 Topics: Amino Acid Sequence; Antigens, Surface; Carboxypeptidases; Cloning, Molecular; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Ion Channels; Male; Membrane Proteins; Molecular Sequence Data; Peptide Fragments; Prostatic Neoplasms; Protein Structure, Secondary; Protein Structure, Tertiary; Protozoan Proteins	2001
Differentiation of human prostate cancer from benign hypertrophy by in vitro 1H NMR. Magnetic resonance in medicine, 1992, Volume: 25, Issue:1 Topics: Alanine; Citrates; Creatine; Glutamates; Glutamic Acid; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Phosphorylcholine; Prostatic Hyperplasia; Prostatic Neoplasms	1992
In vitro proton spectroscopy of normal and abnormal prostate. Magnetic resonance in medicine, 1991, Volume: 19, Issue:2 Topics: Adenocarcinoma; Carbon; Cells, Cultured; Citrates; Citric Acid; Gas Chromatography-Mass Spectrometry; Glutamates; Glutamic Acid; Glutamine; Humans; Ketoglutaric Acids; Lactates; Magnetic Resonance Spectroscopy; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Protons	1991